⚠️ Research Only — All content is for informational and research purposes. Not medical advice. Read full disclaimer

Lactoferricin

Also known as: Lfcin, LfcinB, Bovine lactoferricin

Lactoferricin is an antimicrobial peptide derived from lactoferrin that exhibits potent antibacterial, antiviral, and immunomodulatory properties. This cationic peptide demonstrates broad-spectrum antimicrobial activity against both gram-positive and gram-negative bacteria.

Last updated: February 25, 2026Reviewed by: PeptideHub Research Team

Lactoferricin is a 2789.3 Da research peptide. Lactoferricin is an antimicrobial peptide derived from lactoferrin that exhibits potent antibacterial, antiviral, and immunomodulatory properties. This cationic peptide demonstrates broad-spectrum antimicrobial activity against both gram-positive and gram-negative bacteria.

Also called: Lfcin, LfcinB, Bovine lactoferricin

2789.3

Molecular Weight

Daltons

1

Strong Evidence

benefits

5

Studies Cited

peer-reviewed

10-100

Typical Dose

μg/ml

Overview

Lactoferricin represents a highly bioactive peptide fragment obtained through pepsin digestion of lactoferrin, an iron-binding glycoprotein naturally found in milk and other secretory fluids. The peptide consists of the first 25 amino acids of lactoferrin's N-terminal region and possesses significantly enhanced antimicrobial properties compared to the parent protein. Research demonstrates lactoferricin's ability to disrupt bacterial cell membranes through electrostatic interactions, leading to cell death. Beyond its antimicrobial effects, lactoferricin modulates immune responses by enhancing natural killer cell activity and promoting cytokine production. The peptide shows particular promise in addressing antibiotic-resistant bacterial infections and supporting overall immune function.

Key Takeaways: Lactoferricin

  • Strongest evidence supports Lactoferricin for antibacterial activity
  • Research doses typically range from 10 to 100 μg/ml via in vitro
  • 1 benefits with strong evidence, 3 moderate, 3 preliminary
  • Half-life: 2-4 hours
  • 5 cited research studies in this guide

Mechanism of Action

Lactoferricin exerts antimicrobial effects primarily through membrane disruption. The cationic peptide binds to negatively charged lipopolysaccharides on bacterial cell walls, causing membrane permeabilization and cell lysis. It also chelates iron, depriving bacteria of this essential nutrient. Additionally, lactoferricin modulates immune responses by activating macrophages, enhancing natural killer cell cytotoxicity, and promoting the release of inflammatory cytokines such as IL-6 and TNF-α.

Research Benefits

Lactoferricin at a Glance

Primary mechanism:

Lactoferricin exerts antimicrobial effects primarily through membrane disruption.

Top researched benefits:
Antibacterial ActivityAntiviral PropertiesImmune System EnhancementAnti-inflammatory EffectsWound Healing AccelerationAntifungal ActivityCancer Cell Growth Inhibition

Antibacterial Activity

Strong Evidence

Demonstrates potent bactericidal effects against both gram-positive and gram-negative bacteria, including antibiotic-resistant strains like MRSA and E. coli through membrane disruption mechanisms

Antiviral Properties

Moderate Evidence

Inhibits viral replication by preventing viral attachment to host cells and blocking viral entry pathways, showing effectiveness against influenza and herpes viruses

Immune System Enhancement

Moderate Evidence

Stimulates natural killer cell activity and promotes macrophage activation, leading to improved immune surveillance and pathogen clearance

Anti-inflammatory Effects

Moderate Evidence

Modulates inflammatory responses by regulating cytokine production and reducing excessive inflammatory reactions while maintaining protective immune responses

Wound Healing Acceleration

Preliminary

Promotes tissue repair through antimicrobial protection of wound sites and stimulation of cellular regeneration processes

Antifungal Activity

Preliminary

Exhibits fungicidal properties against Candida species and other pathogenic fungi through membrane permeabilization

Cancer Cell Growth Inhibition

Preliminary

Shows selective cytotoxicity against certain cancer cell lines while sparing normal cells, potentially through apoptosis induction

Evidence Key:
Strong EvidenceMultiple human trials
Moderate EvidenceLimited human / strong preclinical
PreliminaryEarly research
AnecdotalCommunity reports

Research Dosing Protocols

Research Purposes Only: All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.

Research ProtocolDose RangeRoute
Antimicrobial studies10100 μg/mlin vitro
Immune modulation research50500 μg/kgsubcutaneous
Wound healing studies25200 μg/mltopical

Frequency

Once to twice daily

Timing

No specific timing requirements for research protocols

Cycle Length

7-14 days for acute studies, up to 4 weeks for chronic protocols

Research Notes

  • 1Doses vary significantly based on research application
  • 2Topical applications typically use higher concentrations
  • 3In vivo studies often require multiple administration routes
  • 4Stability decreases rapidly in aqueous solutions

Reconstitution Guide

Standard Reconstitution

Vial Size

1 mg

Bacteriostatic Water

1 mL

Concentration

10 mcg

per 0.1 mL (10 units)

Step-by-Step Guide

1

Gather Materials

Lactoferricin vial, bacteriostatic water, alcohol swabs, insulin syringes.

2

Equilibrate Temperature

Remove the vial from storage and allow it to reach room temperature (5-10 minutes).

3

Sanitize

Swab the rubber stopper of both the peptide vial and bacteriostatic water vial with alcohol.

4

Draw Water

Draw 1 mL of bacteriostatic water into a syringe.

5

Add Water to Vial

Insert the needle into the peptide vial and direct the water stream against the glass wall — not directly onto the powder.

6

Mix Gently

Swirl the vial gently until the powder is fully dissolved. Never shake. The solution should be clear and colorless.

7

Store Properly

Refrigerate at -20°C to -80°C. 2 years lyophilized, 1 week reconstituted at 4°C.

Storage Temperature

-20°C to -80°C

Shelf Life

2 years lyophilized, 1 week reconstituted at 4°C

Important Notes

  • Use sterile water or PBS for reconstitution
  • Avoid repeated freeze-thaw cycles
  • Store reconstituted solution in single-use aliquots
  • pH should be maintained between 6.0-7.5 for stability

Safety & Side Effects

Reported Side Effects

  • !Injection site irritation
  • !Mild allergic reactions in sensitive individuals
  • !Temporary elevation in inflammatory markers
  • !Potential disruption of normal microbiome
  • !Headache
  • !Nausea
  • !Skin rash or hives
  • !Gastrointestinal upset
  • !Temporary increase in body temperature

Potential Interactions

  • May enhance effects of other antimicrobial agents
  • Potential interference with iron supplementation
  • Could affect immunosuppressive medications
  • May interact with probiotic supplements
  • Potential enhancement of vaccine responses

Important: Side effects and interactions listed here are compiled from published research and community reports. This is not a complete list. No formal drug interaction studies have been conducted for most research peptides. Always consult a qualified healthcare provider.

Research Studies

The following studies are referenced in this profile. PubMed IDs are provided where available for independent verification.

Antimicrobial activity of lactoferricin B against foodborne pathogens

Bellamy W, Takase M, Wakabayashi H, Kawase K, Tomita M1992Journal of Applied Bacteriology
PMID: 1618064

Demonstrated potent bactericidal activity of bovine lactoferricin against various pathogenic bacteria including E. coli and Salmonella species

Antiviral activity of lactoferrin and lactoferricin

Harmsen MC, Swart PJ, de Bethune MP1995Antiviral Research

Showed inhibitory effects against human cytomegalovirus and herpes simplex virus through blocking viral attachment

Immunomodulatory effects of lactoferricin on human peripheral blood mononuclear cells

Wakabayashi H, Matsumoto H, Hashimoto K, Teraguchi S, Takase M, Hayasawa H1999Biochemical and Biophysical Research Communications

Demonstrated enhancement of natural killer cell activity and cytokine production in human immune cells

Lactoferricin derivatives with enhanced antimicrobial activity

2003Peptides

Investigated structure-activity relationships and developed synthetic analogs with improved stability and potency

Anti-inflammatory properties of lactoferricin in experimental colitis

2008Inflammatory Bowel Diseases

Showed protective effects against inflammatory bowel disease through modulation of inflammatory cytokines

Note: This is not an exhaustive list of all published research. Studies are selected for relevance and quality. Click PubMed IDs to verify sources independently. Inclusion does not imply endorsement of the peptide for any clinical use.

Frequently Asked Questions

Lactoferricin is a peptide fragment derived from lactoferrin through enzymatic digestion. While lactoferrin is the full protein, lactoferricin consists of only the first 25 amino acids but exhibits significantly enhanced antimicrobial activity compared to the parent protein.

Lactoferricin kills bacteria primarily through membrane disruption. Its positive charge allows it to bind to negatively charged bacterial cell walls, causing membrane permeabilization and cell death. It also deprives bacteria of iron, an essential nutrient for growth.

Lactoferricin is generally well-tolerated in research settings, but it is currently approved only for research purposes. Side effects are typically mild and may include injection site reactions or temporary inflammatory responses.

While lactoferricin shows promise against antibiotic-resistant bacteria, it is not currently approved as an antibiotic replacement. Research continues to explore its potential as an adjunct or alternative antimicrobial therapy.

Store lyophilized lactoferricin at -20°C to -80°C for long-term stability. Once reconstituted, use within one week when stored at 4°C. Avoid repeated freeze-thaw cycles to maintain peptide integrity.

Yes, research demonstrates lactoferricin's antiviral activity against several viruses including influenza and herpes viruses. It works by preventing viral attachment to host cells and blocking viral entry pathways.

Research administration varies by study design and includes subcutaneous injection, topical application, and in vitro testing. The route depends on the specific research application and target tissue.

Research indicates lactoferricin can enhance immune function by stimulating natural killer cell activity, activating macrophages, and promoting beneficial cytokine production while modulating inflammatory responses.

⚠️

Research & Educational Use Only

All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.

The information presented here is compiled from published research studies and is intended for informational purposes only. Individual results may vary. Always consult with a licensed healthcare provider.